0001493152-21-010004.txt : 20210429
0001493152-21-010004.hdr.sgml : 20210429
20210429140314
ACCESSION NUMBER: 0001493152-21-010004
CONFORMED SUBMISSION TYPE: 3/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210203
FILED AS OF DATE: 20210429
DATE AS OF CHANGE: 20210429
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Deutsch Corey
CENTRAL INDEX KEY: 0001843944
FILING VALUES:
FORM TYPE: 3/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39785
FILM NUMBER: 21869350
MAIL ADDRESS:
STREET 1: POST OFFICE BOX NO. 1
STREET 2: HARBOR POINT ROAD
CITY: STAMFORD
STATE: CT
ZIP: 06902
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LifeMD, Inc.
CENTRAL INDEX KEY: 0000948320
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
IRS NUMBER: 760238453
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 800 THIRD AVENUE, SUITE 2800
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: (866) 351-5907
MAIL ADDRESS:
STREET 1: 800 THIRD AVENUE, SUITE 2800
CITY: NEW YORK
STATE: NY
ZIP: 10022
FORMER COMPANY:
FORMER CONFORMED NAME: CONVERSION LABS, INC.
DATE OF NAME CHANGE: 20180622
FORMER COMPANY:
FORMER CONFORMED NAME: Immudyne, Inc.
DATE OF NAME CHANGE: 20120514
FORMER COMPANY:
FORMER CONFORMED NAME: IMMUDYNE INC
DATE OF NAME CHANGE: 19950720
3/A
1
ownership.xml
X0206
3/A
2021-02-03
2021-02-05
0
0000948320
LifeMD, Inc.
LFMD
0001843944
Deutsch Corey
C/O LIFEMD, INC.,
800 THIRD AVENUE, SUITE 2800
NEW YORK,
NY
10022
0
1
0
0
Chief Business Officer
Common Stock
48630
D
Options to purchase shares of Common Stock
Common Stock, par value $0.001
25000
D
Options to purchase shares of Common Stock
Common Stock, par value $0.001
175000
D
This Form 3 amendment is being filed to correct the number of shares directly owned Mr. Deutsch as of February 3, 2021.
The shares were purchased by Mr. Deutsch on January 25, 2021, in a private placement offering by the Company.
On February 3, 2021 (the "Effective Date"), Mr. Deutsch and the Issuer entered into First Amendment to Employment Agreement (the "Amended Employment Agreement"), whereby Mr. Deutsch was appointed Chief Business Officer of the Issuer. As of the Effective Date, the Board of Directors of the Issuer has acknowledged the role of Chief Business Officer as an executive officer position.
Pursuant to the terms of the consulting agreement, by and between Mr. Deutsch and the Issuer, dated December 3, 2020, Mr. Deutsch was granted stock options to purchase up to 25,000 shares of the Company's common stock at an exercise price of $8.25 per share (the "Consultancy Stock Options"). The Consultancy Stock Options vested on December 3, 2020.
Pursuant to the terms of the employment agreement, by and between Mr. Deutsch and the Issuer, dated January 14, 2021, Mr. Deutsch was granted stock options to purchase up to 175,000 shares of the Company's common stock at an exercise price of $7.07 per share (the "Stock Options"). The Stock Options shall vest in equal monthly tranches, based on the passage of time, over the 36 months, beginning on the Effective Date.
/s/ Corey Deutsch
2021-04-29